Osso VR, the VR surgical training platform, today announced it’s closed a $66 million Series C financing round, something the company says will be used to broaden its VR surgical offering and hire more expert talent.
The Series C round was led by Oak HC/FT, which includes participation from Signalfire, GSR Ventures, Tiger Global Management and Kaiser Permanente Ventures.
This brings the company’s lifetime outside investment to around $109 million, with its $27 million Series B arriving in July 2021.
Founded in late 2016 by UCLA and Harvard-trained orthopedic surgeon Justin Barad, MD, Osso VR’s surgical training tech provides on-demand, educational experiences to surgeons with a focus on acquainting them with emerging techniques and technologies. The company works with industry leaders such as Johnson & Johnson, Stryker, Zimmer Biomet and Smith & Nephew.
More recently, Osso VR made strides during the COVID-19 pandemic since its VR training allows medical professionals to learn and practice from a distance. It provides modules across a number of fields, including orthopedics, endoscopy, and a host of interventional procedures.
The company has now grown to more than 150 employees, and Osso VR says it plans to grow “exponentially” over the next year.
“The future at Osso VR is incredibly bright. Each step of the way, we’ve stayed true to our mission to democratize healthcare and seen the results that our platform brings to surgical training and assessment,” said Barad. “This round of investment supports the next step of our journey to provide access to all healthcare professionals. I couldn’t be more excited to take this next step with such a talented, passionate team.”
